Our motto is simple yet ambitious—everything for everyone, everywhere. I wish for peace, health, and reflection on our shared humanity in these challenging times
In Conversation
Leveraging this resource [the Systeme National des Donnees de Sante (SNDS)], we conduct numerous real-world studies, positioning France among the leaders in real-world evidence generation within…
Egypt is a place where it takes longer to do business, there are hurdles because we have a huge administration and bureaucracy, but it is worth…
Since the beginning of the company’s transformational journey in 2016 we have tripled our client base and today a wide range of mostly international companies –…
In order to increase the robustness of the global supply chain, CDMOs need to step up and play a larger role than ever before and need…
Claire Mounier-Vehier – Cardiologist, Head of Vascular Medicine & Hypertension, Heart & Lung Institute of the University Hospital of Lille, Honorary President of the French Federation of Cardiology
My message is very simple: listen to yourself, get tested, and pass the message to others. Doctors also have a responsibility; we need to change the…
Francois Cornu – President Eurofins Biomnis & Gautier Decock – Managing Director Eurofins BPT France and Belgium
We invest heavily into our technology and systems to best accelerate our clients’ projects – Eurofins understands that time to market is critical, no matter the…
Nathalie Giraud – Director of Integrated Monitoring Investigator Services (IMIS) & Head of France, PPD
It is important we continue efforts to streamline our local processes to maximize all the potential France has and to bring more clinical trials to patients
In a nutshell, Fagron is now addressing doctors as new partners in France to help them find the most appropriate personalized treatment for their patients
There is a strong link between health and beauty. While many diseases have a negative impact on outward appearance, treatments can also produce negative side effects…
We need to look beyond French borders and have been actively looking for investors in the US as this is where the relevant institutional investors are
The TREM-1 pathway can be used to develop treatments for different indications besides septic shock, including cardiovascular diseases and chronic inflammatory conditions, which could be interesting…